journal article·2005-05

Synthesis and characterization of the paclitaxel/MPEG-PLA block copolymer conjugate

Xuefei Zhang, Yuxin Li, Xuesi Chen, Xiuhong Wang, Xiaoyi Xu, Qizhi Liang, Junli Hu, Xiabin Jing

Biomaterials· Volume 26· Issue 14
Publisher page

Abstract

A paclitaxel/MPEG-PLA block copolymer conjugate was prepared in three steps: (1) hydroxyl-terminated diblock copolymer of monomethoxy-poly(ethylene glycol)-b-poly(lactide) (MPEG-PLA) was synthesized by ring-opening polymerization of L-lactide using MPEG as a maroinitiator; (2) it was converted to carboxyl-terminated MPEG-PLA by reacting with mono-t-butyl ester of diglycolic acid and subsequent deprotecting the t-butyl group with TFA; (3) the latter was reacted with paclitaxel in the presence of dicyclohexylcarbodiimide and dimethylaminopyridine. Structures of the polymers synthesized were confirmed by (1)H NMR, and their molecular weights were determined by gel permeation chromatography. The antitumor activity of the conjugate against human liver cancer H7402 cells was evaluated by MTT method. The results showed that paclitaxel can be released from the conjugate without losing cytotoxicity.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Cancer Treatment and Pharmacology · Nanoparticle-Based Drug Delivery · biodegradable polymer synthesis and properties

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (27)

Show source-provided references
1. Permanent hepatic artery embolization with dextran micropheres in 131 patients with unresectable hepatocellular carcinoma
2. Paclitaxel—a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer10.2165/00003495-199448050-00009 ↗
3. Chemotherapy for advanced ovarian cancer
4. Weekly paclitaxel in advanced non-small cell lung cancer10.1053/sonc.2001.27607 ↗
5. Metastatic breast cancer with resistance to both anthracycline and docetaxel successfully treated with weekly paclitaxel10.1007/PL00012081 ↗
7. Paclitaxel and its formulations10.1016/S0378-5173(01)00986-3 ↗
8. Development of nonionic surfactant/phospholipid o/w emulsion as a paclitaxel delivery system10.1016/S0168-3659(98)00164-3 ↗
9. Novel taxol formulations10.1023/A:1018994111594 ↗
10. Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations10.1016/S0169-409X(02)00016-9 ↗
11. Taxol-loaded block copolymer nanospheres composed of methoxy poly(ethylene glycol) and poly(ε-caprolactone) as novel anticancer drug carriers10.1016/S0142-9612(00)00292-1 ↗
12. Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid)(PLA-PEG-PLA) microspheres for controlled release of paclitaxel10.1016/S0142-9612(03)00419-8 ↗
13. Nanoparticles of biodegradable polymers for clinical administration of paclitaxel10.2174/0929867043455909 ↗
14. Methoxy poly (ethylene glycol)-poly (lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs10.1016/j.biomaterials.2003.09.055 ↗
15. Synthesis of Congeners and Prodrugs. 3. Water-soluble prodrugs of taxol with potent antitumor activity10.1021/jm00124a011 ↗
16. Drug delivery systems10.1021/jm950475e ↗
17. Prodrugs of peptides and proteins for improved formulation and delivery10.1146/annurev.pa.33.040193.002513 ↗
18. Synthesis and evaluation of some water-soluble prodrugs and derivatives of paclitaxel with antitumor activity10.1021/jm00079a019 ↗
19. Modified taxols. 6. Preparation of water-soluble prodrugs of taxol10.1021/np50078a018 ↗
20. Phosphatase-activated prodrugs of paclitaxel
21. Preclinical antitumor activity of water-soluble paclitaxel derivatives10.1007/s002800050603 ↗
22. Complete regression of well-established tumors using a Novel Water-soluble poly (l-glutamic acid)-paclitaxel conjugate
23. Polymer-bound paclitaxel derivatives
24. Antitumor activity of paclitaxel-2′-glycinate conjugated to poly (ethylene glycol)
25. Toxic characteristics of methoxy poly(ethylene glycol)/poly(ε-caprolactone) nanospheres; in vitro and in vivo studies in the normal mice10.1016/S0142-9612(02)00248-X ↗
26. Design, synthesis and biological activity of protaxols10.1038/364464a0 ↗
27. Antitumor agents 210. synthesis and evaluation of taxoid-epipodophyllotoxin conjugates as novel cytotoxic agents10.1016/S0968-0896(01)00206-1 ↗